This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (311) Obstetrics, Gynecology, and Reproductive Medicine (225) Medication Adherence (84) Pregnancy Information, Education and Lifestyle Interventions (300) Pharmacology and Pharmaceutics (66)

Published on in Vol 10, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29208, first published .
Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study

Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study

Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study

Authors of this article:

Alison Edelman1 Author Orcid Image ;   Agnes Hemon2 Author Orcid Image ;   Mitchell Creinin3 Author Orcid Image ;   Pascale Borensztein2 Author Orcid Image ;   Bruno Scherrer4 Author Orcid Image ;   Anna Glasier5 Author Orcid Image
Article Authors Cited by (3) Tweetations (1) Metrics

Journals

  1. Glasier A, Edelman A, Creinin M, Brache V, Westhoff C, Han L, Chen M, Hemon A. The effect of deliberate non-adherence to a norgestrel progestin-only pill: A randomized, crossover study. Contraception 2023;117:1 View
  2. Han L, Creinin M, Hemon A, Glasier A, Chen M, Edelman A. Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception. Contraception 2022;112:43 View
  3. Glasier A, Edelman A, Creinin M, Han L, Matulich M, Brache V, Westhoff C, Hemon A. Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity. Contraception 2022;112:37 View